Imrab 3 TF (Canada)

Rabies Vaccine

Killed Virus

Rabies 3 Year TF

Description

: IMRAB^® 3 TF contains the same virus strain that is used in the Pasteur Merieux Connaught human vaccine. The virus is grown in a stable cell line, inactivated, and mixed with a safe and potent adjuvant. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible animals.

Imrab 3 TF Indications

: IMRAB^® 3 TF is recommended for the vaccination of healthy cats, dogs, and ferrets 12 weeks of age and older for prevention of disease due to rabies virus.

DOSAGE: Aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy cats or dogs. Revaccinate 1 year later, then every 3 years. Inject 1 mL (1 dose) subcutaneously in healthy ferrets. Revaccinate ferrets annually.

PRECAUTIONS: Store at 2-7°C (35-45°F). Do not freeze. Shake well before using. Do not use chemicals to sterilize syringes and needles. Contains gentamicin as a preservative. This product does not contain thimerosal. A transient local reaction may occur at the injection site following subcutaneous administration. Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection site fibrosarcomas. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.

SOLD TO VETERINARIANS ONLY.

For Veterinary Use Only.

IMRAB is a registered trademark of MERIAL.

Manufactured By MERIAL, INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 4B6

CPN: 11820791